Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
At present, there are not much data on the clinical use of live recombinant viral vector vaccines. Characteristics of new vaccines should be factored into requirements/recommendations for quality control, preclinical and clinical studies of vaccines in order to enable further risk/benefit assessment...
Saved in:
Main Authors: | L. M. Khantimirova, D. V. Gorenkov, S. G. Guseva, V. A. Merkulov, A. A. Soldatov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2021-12-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/326 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical Studies of the Specific Activity of the Live Culture Vaccine VACD6 against Smallpox and other Orthopoxvirus Infections
by: S. N. Shchelkunov, et al.
Published: (2023-01-01) -
Current regulatory requirements for clinical trials of viral vaccines
by: A. A. Soldatov, et al.
Published: (2023-12-01) -
Preclinical and clinical development of preventive rotavirus vaccines: special considerations
by: A. S. Korovkin, et al.
Published: (2024-12-01) -
Human papillomavirus vaccines: organisation and experience of preclinical studies
by: A. S. Korovkin, et al.
Published: (2024-10-01) -
Accelerating vaccine development: Plug-and-play platforms for emerging infectious diseases
by: Kairui Yang
Published: (2025-08-01)